HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 276, Issue 12, 9123-9132, March 23, 2001

This Article Full Text Full Text (PDF) All Versions of this Article: 276/12/9123    most recent M009270200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zeitlmann, L. Articles by Kolanus, W. Search for Related Content PubMed PubMed Citation Articles by Zeitlmann, L. Articles by Kolanus, W. Social Bookmarking                      What's this?

Cloning of ACP33 as a Novel Intracellular Ligand of CD4^*

Lutz Zeitlmann^§, Pinar Sirim^§, Elisabeth Kremmer^¶, and Waldemar Kolanus

From the  Laboratorium für Molekulare Biologie-Genzentrum der Universität München, and the ^¶ GSF-Institut für Molekulare Immunologie, D-81377 München, Germany

CD4 recruitment to T cell receptor (TCR)-peptide-major histocompatibility class II complexes is required for stabilization of low affinity antigen recognition by T lymphocytes. The cytoplasmic portion of CD4 is thought to amplify TCR-initiated signal transduction via its association with the protein tyrosine kinase p56^lck. Here we describe a novel functional determinant in the cytosolic tail of CD4 that inhibits TCR-induced T cell activation. Deletion of two conserved hydrophobic amino acids from the CD4 carboxyl terminus resulted in a pronounced enhancement of CD4-mediated T cell costimulation. This effect was observed in the presence or absence of p56^lck, implying involvement of alternative cytosolic ligands of CD4. A two-hybrid screen with the intracellular portion of CD4 identified a previously unknown 33-kDa protein, ACP33 (acidic cluster protein 33), as a novel intracellular binding partner of CD4. Since interaction with ACP33 is abolished by deletion of the hydrophobic CD4 C-terminal amino acids mediating repression of T cell activation, we propose that ACP33 modulates the stimulatory activity of CD4. Furthermore, we demonstrate that interaction with CD4 is mediated by the noncatalytic / hydrolase fold domain of ACP33. This suggests a previously unrecognized function for / hydrolase fold domains as a peptide binding module mediating protein-protein interactions.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				P A Wilkinson, M A Simpson, L Bastaki, H Patel, J A Reed, K Kalidas, E Samilchuk, R Khan, T T Warner, and A H Crosby A new locus for autosomal recessive complicated hereditary spastic paraplegia (SPG26) maps to chromosome 12p11.1-12q14 J. Med. Genet., January 1, 2005; 42(1): 80 - 82. [Full Text] [PDF]

				S. Harding, P. Lipp, and D. R. Alexander A Therapeutic CD4 Monoclonal Antibody Inhibits TCR-{zeta} Chain Phosphorylation, {zeta}-Associated Protein of 70-kDa Tyr319 Phosphorylation, and TCR Internalization in Primary Human T Cells J. Immunol., July 1, 2002; 169(1): 230 - 238. [Abstract] [Full Text] [PDF]